MHRA – Page 183 – Pharma.Tips

Hold Time Bioburden Rise after supplier change: investigation steps with CAPA evidence

Investigating Hold Time Bioburden Increase Following a Supplier Change: Effective Steps for CAPA In the fast-paced world of pharmaceutical manufacturing, changes in suppliers can lead to unforeseen challenges, including Quality…

Microbial Limits Failure in dental gel manufacturing: packaging compatibility and shelf-life justification

Investigating Microbial Limits Failure in Dental Gel Manufacturing: Insights on Packaging Compatibility and Shelf-Life Justification The pharmaceutical manufacturing industry faces numerous challenges, particularly when producing dental gels where microbial limits…

Flavor Instability after packaging change: manufacturing vs lab root cause assessment

Investigating Flavor Instability Post-Packaging Change in Pharmaceutical Manufacturing Flavor stability is crucial in pharmaceutical products, especially in dental dosage forms where taste plays a significant role in patient compliance. When…

Fill Weight Variability at accelerated stability: manufacturing vs lab root cause assessment

Assessing Root Causes of Fill Weight Variability in Accelerated Stability Studies In pharmaceutical manufacturing, maintaining consistent fill weights during production is critical, particularly when evaluating products under accelerated stability conditions.…

Ph Drift at accelerated stability: sanitation, water, and EM checks

Addressing pH Drift During Accelerated Stability Testing: Essential Investigative Steps pH drift observed during accelerated stability testing can pose significant challenges within pharmaceutical manufacturing, potentially impacting product quality and compliance.…

Pet Failure during bulk hold: packaging compatibility and shelf-life justification

Addressing Pet Failure during Bulk Hold: Ensuring Packaging Compatibility and Shelf-Life Justification In pharmaceutical manufacturing, the issue of Pet Failure during bulk hold can pose significant challenges to product integrity…

Flavor Instability in dental gel manufacturing: packaging compatibility and shelf-life justification

Addressing Flavor Instability in Dental Gel Production: A Comprehensive Investigation Approach Flavor instability in dental gel manufacturing can lead to significant quality issues, affecting consumer satisfaction and compliance with regulatory…

Fill Volume Variability during bulk hold: sanitation, water, and EM checks

Understanding and Investigating Fill Volume Variability During Bulk Hold Stages Fill volume variability can present significant challenges in pharmaceutical manufacturing, particularly during bulk hold stages of production. When discrepancies occur,…

Fill Weight Variability in dental paste filling: manufacturing vs lab root cause assessment

Root Cause Analysis of Fill Weight Variability in Dental Paste Manufacturing Fill weight variability in dental paste filling poses significant challenges for pharmaceutical manufacturers, potentially leading to deviations and nonconformance…

Phase Separation in dental paste filling: manufacturing vs lab root cause assessment

Root Cause Investigation for Phase Separation in Dental Paste Filling During Manufacturing and Lab Assessments In the pharmaceutical manufacturing of dental dosage forms, particularly dental paste fillings, phase separation can…

Tube Leakage Complaint in dental paste filling: packaging compatibility and shelf-life justification

Addressing Tube Leakage Issues in Dental Paste Filling: An Investigation Framework Complaints concerning tube leakage in dental paste filling can significantly impact product quality and shelf life, necessitating a thorough…

Assay Oos during line setup: investigation steps with CAPA evidence

Investigation Steps for Assay OOS During Line Setup in Pharmaceutical Manufacturing In the fast-paced world of pharmaceutical manufacturing, deviations from expected assay results can trigger significant operational challenges, especially during…